
EXCLUSIVE: Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models
Silo Pharma, Inc. SILO on Wednesday released results for its preclinical study evaluating SP-26. SP-26 is a ketamine-based injectable dissolvable polymer implant for chronic pain and fibromyalgia. If clinically successful, SP-26 could qualify for the FDA…